EMS-CHEMIE HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 730.5 CHF | +2.38% |
|
+6.18% | +7.27% |
| Apr. 25 | EMS-Chemie Q1 Net Sales Decline | MT |
| Feb. 14 | Bank Vontobel Lowers Price Target on EMS-Chemie, Maintains Hold Recommendation | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 14,887 | 19,951 | 23,880 | 14,642 | 15,928 | 17,086 | - | - |
| Enterprise Value (EV) 1 | 14,655 | 19,818 | 23,789 | 14,406 | 15,696 | 16,708 | 16,657 | 16,583 |
| P/E ratio | 28.2 x | 45.3 x | 43.4 x | 27.5 x | 34.8 x | 37.5 x | 33.9 x | 31 x |
| Yield | 2.45% | 1.52% | 2.06% | 3.19% | 1.87% | 2.4% | 2.66% | 2.87% |
| Capitalization / Revenue | 6.91 x | 11.1 x | 10.6 x | 6 x | 7.28 x | 7.7 x | 7.19 x | 6.78 x |
| EV / Revenue | 6.81 x | 11 x | 10.6 x | 5.9 x | 7.17 x | 7.53 x | 7.01 x | 6.58 x |
| EV / EBITDA | 21.6 x | 34.8 x | 34.2 x | 21.8 x | 29 x | 28.2 x | 25.4 x | 23.2 x |
| EV / FCF | 30 x | 46.8 x | 54.3 x | 53 x | 29.8 x | 41.2 x | 36.9 x | 33.5 x |
| FCF Yield | 3.34% | 2.14% | 1.84% | 1.89% | 3.36% | 2.43% | 2.71% | 2.98% |
| Price to Book | 8.95 x | 12.5 x | 13.3 x | 8.06 x | 9.14 x | 9.25 x | 8.85 x | 8.45 x |
| Nbr of stocks (in thousands) | 23,389 | 23,389 | 23,389 | 23,389 | 23,389 | 23,389 | - | - |
| Reference price 2 | 636.5 | 853.0 | 1,021 | 626.0 | 681.0 | 730.5 | 730.5 | 730.5 |
| Announcement Date | 2/7/20 | 2/12/21 | 2/11/22 | 2/10/23 | 2/9/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,153 | 1,802 | 2,254 | 2,442 | 2,189 | 2,219 | 2,375 | 2,520 |
| EBITDA 1 | 677 | 569 | 696 | 661 | 542 | 592.7 | 656.3 | 713.9 |
| EBIT 1 | 624 | 515 | 640 | 611 | 493 | 539.9 | 601.2 | 656.6 |
| Operating Margin | 28.98% | 28.58% | 28.39% | 25.02% | 22.52% | 24.33% | 25.31% | 26.06% |
| Earnings before Tax (EBT) 1 | 621 | 519 | 641 | 607 | 492 | 541.9 | 592.6 | 642.8 |
| Net income 1 | 532 | 440 | 550.3 | 535 | 461 | 460.6 | 504.4 | 553 |
| Net margin | 24.71% | 24.42% | 24.42% | 21.91% | 21.06% | 20.76% | 21.24% | 21.95% |
| EPS 2 | 22.54 | 18.81 | 23.53 | 22.75 | 19.56 | 19.49 | 21.56 | 23.57 |
| Free Cash Flow 1 | 489.2 | 423.2 | 438.4 | 271.9 | 527.1 | 405.7 | 451.7 | 494.9 |
| FCF margin | 22.72% | 23.49% | 19.45% | 11.14% | 24.08% | 18.28% | 19.02% | 19.64% |
| FCF Conversion (EBITDA) | 72.26% | 74.38% | 62.99% | 41.14% | 97.25% | 68.44% | 68.83% | 69.31% |
| FCF Conversion (Net income) | 91.95% | 96.19% | 79.66% | 50.83% | 114.33% | 88.09% | 89.55% | 89.49% |
| Dividend per Share 2 | 15.60 | 13.00 | 21.00 | 20.00 | 12.75 | 17.50 | 19.43 | 21.00 |
| Announcement Date | 2/7/20 | 2/12/21 | 2/11/22 | 2/10/23 | 2/9/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 996 | 849 | 953 | 1,166 | 525 | 563 | 1,088 | 638 | 646 | 1,284 | 587 | 571 | 1,158 | 1,183 | 514 | 492 | 544.4 | 562.4 | 1,110 | 1,083 |
| EBITDA | 331 | 256 | 315 | 349 | - | - | 347 | - | - | 354 | - | - | 307 | 306 | - | - | - | - | 269.5 | 288.7 |
| EBIT | 308 | 229 | 288 | 321 | - | - | 318 | - | - | 324 | - | - | 287 | 280 | - | - | - | - | 244.4 | 263.7 |
| Operating Margin | 30.92% | 26.97% | 30.22% | 27.53% | - | - | 29.23% | - | - | 25.23% | - | - | 24.78% | 23.67% | - | - | - | - | 22.03% | 24.35% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income | - | 191 | - | 278 | - | - | - | - | - | 285 | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | 22.5% | - | 23.84% | - | - | - | - | - | 22.2% | - | - | - | - | - | - | - | - | - | - |
| EPS | - | 8.180 | - | 11.91 | - | - | - | - | - | 12.20 | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | 15.60 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/7/20 | 7/10/20 | 2/12/21 | 7/16/21 | 10/28/21 | 2/11/22 | 2/11/22 | 4/27/22 | 7/15/22 | 7/15/22 | 10/25/22 | 2/10/23 | 2/10/23 | 7/14/23 | 10/31/23 | 2/9/24 | - | - | - | - |
1CHF in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 232 | 133 | 91.2 | 235 | 232 | 378 | 428 | 503 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 489 | 423 | 438 | 272 | 527 | 406 | 452 | 495 |
| ROE (net income / shareholders' equity) | 31.7% | 27.2% | 30.6% | 29.3% | 26.3% | 25.8% | 27.7% | 27.9% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 71.10 | 68.30 | 76.90 | 77.60 | 74.50 | 78.90 | 82.60 | 86.40 |
| Cash Flow per Share 2 | 23.60 | 20.20 | 22.20 | 15.60 | 24.70 | 26.70 | 26.60 | 30.20 |
| Capex 1 | 62.9 | 48.3 | 79.9 | 94 | 49.4 | 56 | 61.9 | 79.4 |
| Capex / Sales | 2.92% | 2.68% | 3.55% | 3.85% | 2.26% | 2.52% | 2.61% | 3.15% |
| Announcement Date | 2/7/20 | 2/12/21 | 2/11/22 | 2/10/23 | 2/9/24 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
730.5
CHF
Average target price
664.3
CHF
Spread / Average Target
-9.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.27% | 18.68B | |
| +11.47% | 63.22B | |
| -3.47% | 46.34B | |
| +13.72% | 39.97B | |
| +17.83% | 25.46B | |
| -0.57% | 17.24B | |
| -21.73% | 15.81B | |
| +0.22% | 14.9B | |
| -19.10% | 13.74B | |
| +35.12% | 12.81B |
- Stock Market
- Equities
- EMSN Stock
- Financials EMS-CHEMIE HOLDING AG
